March 20, 2007

The Damaging Impact of PDUFA and Why It Should be Repealed

The prescription drug user fee act (PDUFA, 1992), which is up for renewalthis year, linked the Food

Read More
The Damaging Impact of PDUFA and Why It Should be Repealed

February 6, 2007

Pharma Spin and Child Suicide Rates

According to the Center for Disease Control and Prevention’s Annual Summary of Vital Statistics, the suicide rate

Read More
Pharma Spin and Child Suicide Rates

February 3, 2007

Journal Publishers Hire PR “Pit Bull” to Attack Open Access_Nature

Dezenhall was reported by Business Week to have used money from oil giant ExxonMobil to criticize the

Read More
Journal Publishers Hire PR “Pit Bull” to Attack Open Access_Nature

January 30, 2007

A Salem Witch Trial by British Psychological Society

Lisa Blakemore Brown, an accomplished child psychologist who happens to disagree with positions held by powerful academics,

Read More
A Salem Witch Trial by British Psychological Society

January 22, 2007

Role of Litigation in Defining Drug Risks_JAMA / BMJ

Below are excerpts from two timely articles that offer persuasive arguments backed by evidence demonstrating that litigation

Read More
Role of Litigation in Defining Drug Risks_JAMA / BMJ

January 21, 2007

Are Lipid lowering (Statins) Guidelines Evidence-Based? Lancet

A Commentary in the Lancet by John Abramson, MD, of Harvard Medical School, author of Overdosed America,

Read More
Are Lipid lowering (Statins) Guidelines Evidence-Based? Lancet

December 18, 2006

Thinking Can Change the brain

Below are excerpts selected by Sharon Begley, Wall Street Journal science columnist, from her own book, “Train

Read More
Thinking Can Change the brain

December 11, 2006

Critique of FDA’s latest SSRI Data Analysis

The ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP)Promoting Openness, Full Disclosure, and Accountabilitywww.ahrp.org PRESS BRIEFING Bullet points: Critique

Read More
Critique of FDA’s latest SSRI Data Analysis

November 26, 2006

Negative Research Results–Mostly Concealed in Journals_SharonBegley, WSJ

A recent engaging column by Sharon Begley, Wall Street Journal (below), underscores the importance of publishing both

Read More
Negative Research Results–Mostly Concealed in Journals_SharonBegley, WSJ

October 3, 2006

Antipsychotics, Newer Isn’t BetterDrug_Washington Post front page

Shankar Vedantam of The Washington Post reports (below) “a study published yesterday overturns conventional wisdom about antipsychotic drugs,

Read More
Antipsychotics, Newer Isn’t BetterDrug_Washington Post front page

August 25, 2006

Marketing Suicide by Misapplying Population Trends_No Competing Interests?

Neither aggregate suicide rates nor the individuals who commit suicide, are predictable, and no intervention has ever

Read More
Marketing Suicide by Misapplying Population Trends_No Competing Interests?

August 1, 2006

A Cure for Public Distrust: Journals Must Exercise Their Authority as Gatekeeper

An article in Science section of The New York Times is an exmple of its efforts to

Read More
A Cure for Public Distrust: Journals Must Exercise Their Authority as Gatekeeper

June 27, 2006

NEJM Vioxx Safety Correction / Consumers International Accuses Industry–Unscrupulous Marketing

The published correction issued by the NEJM to Merck’s critical study of of its painkiller Vioxx, contradicts

Read More
NEJM Vioxx Safety Correction / Consumers International Accuses Industry–Unscrupulous Marketing

June 7, 2006

“Do Antidepressants Cure or Create Abnormal Brain States?”

In their provocative essay, Dr. Joanna Moncrieff of University College London and Professor David Cohen* of Florida

Read More
“Do Antidepressants Cure or Create Abnormal Brain States?”